Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPO-13 in Patients Undergoing Colonoscopy
NCT04097574Phase 2Completed
- Sponsor
- Nihon Pharmaceutical
- Start
- Aug 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of l-Menthol in colonic spasm (3 arms), sponsored by Nihon Pharmaceutical. Primary endpoint: Proportion of No or Mild colonic spasm at all sites of NPO-13 treatment at 3 minutes. Started Aug 2019; status: completed.
02
Drugs
l-Menthol
03
Conditions
colonic spasm
Beyond the preview
Go deeper on NCT04097574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04097574.